Mark B. Carbeau, Chief Executive Officer at INTERLEUKIN GENETICS INC (ILIU), bought 201,206 shares at $0.10 ($20K) on 2016-07-29, disclosed to the SEC on 2016-08-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.10 | 100,603 | $10K | 49.8% |
| 2 | $0.10 | 100,603 | $10K | 50.2% |
| Total | $0.10 avg | 201,206 | $20K | 100% |